For example, MOF is frequently downregulated in 41% of patients with primary breast carcinoma and in 79% of patients with medulloblastoma, and its protein expression is tightly correlated with acetylated H4 at K16 in all tested samples [60]. Here, KRT16 is linked to breast carcinoma.